A new @NYULangone study finds GLP-1 agonists (Ozempic, Wegovy & more) cut the risk of organ failure by 49% & lower mortality by 31% for kidney transplant recipients with type 2 diabetes—though careful eye health monitoring is key. #Ozempic #mounjaro #kidneytransplantrecipient Learn more: nyulangone.org/doctors/1043483191/babak-j-orandi/appointment/new-patient/10017001